Form D — AltrixBio, Inc.
0001080368-25-000012 · filed Jun 13, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Reported offering amount
- $10,000,000
- Reported amount sold
- $1,150,015
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- AltrixBio, Inc.
- CIK
- 2040517
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 110 Canal Street
Lowell, Massachusetts 01852 - Phone
- 302-658-7581
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nancy Briefs · Executive OfficerLowell, Massachusetts Find on LinkedIn ↗
-
John Brooks · DirectorLowell, Massachusetts Find on LinkedIn ↗
-
Jeffrey Karp · DirectorLowell, Massachusetts Find on LinkedIn ↗
-
Ali Tavakkoli · DirectorLowell, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗